ETokyo, eJapan - (ngoNovemba 15, 2022) - uDaiichi Sankyo (TSE: 4568) namhlanje ubhengeze ukuba kulingo lovavanyo lokusebenza kunye nokhuseleko logonyo lwe-booster nge-DS-5670, isitofu sokugonya se-mRNA ngokuchasene nenoveli yesifo esosulelayo se-coronavirus (COVID-19). -19) iphuhliswe ngu-Daiichi Sankyo (emva koku, uvavanyo lokugonywa kwe-booster), isiphelo sokuqala siphunyeziwe.Ulingo logonyo lwe-booster luquka malunga nama-5,000 abantu abadala baseJapan abasempilweni kunye nezifundo ezisele zikhulile abagqibe uthotho lweprayimari (iidosi ezimbini) zezitofu zokugonya ze-mRNA ezivunyiweyo eJapan ubuncinci kwiinyanga ezintandathu phambi kokubhaliswa.NgoJanuwari ka-2022, ulingo lwaqaliswa njengenqanaba loku-1/2/3 lovavanyo ukuze kuvavanywe ukusebenza kunye nokhuseleko logonyo lwe-booster nge-DS-5670 kusetyenziswa ugonyo lwe-mRNA olwamkelwe eJapan njengolawulo.I-GMFR yokunciphisa i-antibody titer ngokuchasene ne-SARS-CoV-2 (ubunzima bokuqala) egazini kwiiveki ezine emva kogonyo lwe-booster, isiphelo sokuqala solingo lokugonya i-booster, ibonise idatha ephezulu kunye nokungathobeki kwe-DS-5670 kugonyo lwe-mRNA. original strain) evunyiweyo eJapan, ukufezekisa injongo ekujoliswe kuyo.Akukho zinkxalabo zokhuseleko zichongiwe.Iziphumo ezineenkcukacha zolingo logonyo lwe-booster ziya kuboniswa kwiinkomfa zezifundo nakumaphepha ophando.Ngokusekwe kwiziphumo zovavanyo, uDaiichi Sankyo uya kuqhubeka nokulungiselela usetyenziso lwechiza elitsha lesitofu sokugonya se-mRNA ngoJanuwari 2023. Ukongeza, uDaiichi Sankyo uceba ukuqhuba iimvavanyo zeklinikhi zogonyo lwe-bivalent yohlobo lokuqala kunye noxinzelelo lwe-Omicron ngokuchasene ne-coronavirus entsha, eziqhubeka ziguquka.U-Daiichi Sankyo uza kuzama ukomeleza uphuhliso lwesitofu sokugonya se-mRNA kunye nenkqubo yokuvelisa ukuqinisekisa unikezelo oluzinzileyo ngamaxesha aqhelekileyo kunye nokubonelela ngokukhawuleza kwezitofu zokugonya xa kuqhambuko lwezifo ezosulelayo ezivelayo kunye neziphinda zivele.
Malunga ne-DS-5670 DS-5670 sisitofu sokugonya se-mRNA ngokuchasene ne-COVID-19 kusetyenziswa itekhnoloji yokuhanjiswa kwe-nucleic acid efunyenwe nguDaiichi Sankyo, eyilelwe ukuvelisa izilwa-buhlungu ezichasene ne-receptor binding domain (RBD) ye-spike protein yenoveli coronavirus, kwaye ke ngoko. kulindeleke ukuba ibe nothintelo olunqwenelekayo ngokuchasene nokhuseleko lwe-COVID-19 kunye no-2.Ngaphaya koko, i-Daiichi Sankyo ijolise kwizitofu zokugonya ze-mRNA ezinokusasazwa kuluhlu lobushushu obufakwe efrijini (2-8°C)
Ixesha lokuposa: Dec-17-2022
